cost-effective medicines

A recently published report, sponsored by Novartis, has described the potential benefits of the NHS only paying for drugs that actually work as a new model to address affordability and reduce risks within the health system. Read more


The Association of the British Pharmaceutical Industry (ABPI) has confirmed its application for a Judicial Review over the new procedures, from NICE, to restrict access to cost-effective medicines Read more